Phosphorylation of c-Myc at Ser62 via the protein kinase activity of acetaldehyde dehydrogenase 18A1 promotes tumor growth

  • 0Department of Stem Cell and Regenerative Medicine, International Joint Research Center for Precision Biotherapy, Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, China; Jin-feng Laboratory, Chongqing 401329, China.

Summary

This summary is machine-generated.

Acetaldehyde dehydrogenase 18A1 (ALDH18A1) phosphorylates and stabilizes the oncoprotein c-Myc, promoting cancer. Inhibiting this ALDH18A1-MYC interaction with thonzonium bromide (TB) shows therapeutic potential in preclinical cancer models.

Area Of Science

  • Biochemistry
  • Molecular Biology
  • Oncology

Background

  • The oncoprotein c-Myc is crucial in cancer, and its stability influences therapeutic strategies.
  • Phosphorylation at Ser62 is a key mechanism that prevents c-Myc degradation, extending its half-life.

Purpose Of The Study

  • To identify kinases regulating c-Myc phosphorylation at Ser62 for novel cancer interventions.
  • To elucidate the role of acetaldehyde dehydrogenase 18A1 (ALDH18A1) in c-Myc regulation and cancer development.

Main Methods

  • Investigated ALDH18A1's kinase activity using its γ-glutamate kinase (γ-GK) domain.
  • Analyzed the feedback loop between ALDH18A1 and c-Myc expression.
  • Screened FDA-approved drugs for inhibitors of the ALDH18A1-c-Myc interaction.

Main Results

  • ALDH18A1 acts as a protein kinase, phosphorylating c-Myc at Ser62 and suppressing its degradation.
  • A positive feedback loop between ALDH18A1 and c-Myc promotes tumor development.
  • Thonzonium bromide (TB) inhibits ALDH18A1-mediated c-Myc phosphorylation and reduces tumor progression in preclinical models.

Conclusions

  • ALDH18A1 is a novel kinase that stabilizes c-Myc, creating a regulatory circuit driving cancer.
  • Targeting the ALDH18A1-MYC axis with inhibitors like TB offers a promising therapeutic strategy for human cancers.

Related Concept Videos

mTOR Signaling and Cancer Progression 03:03

3.9K

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Abnormal Proliferation 02:23

4.6K

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

PI3K/mTOR/AKT Signaling Pathway 01:22

3.9K

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...

Anaphase Promoting Complex 00:50

2.9K

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...

Induced Pluripotent Stem Cells 01:06

4.4K

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...

Covalently Linked Protein Regulators 02:04

7.1K

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....